Employees of Juul Labs are resisting a deal with Altria, which is also holding talks with cannabis producer Cronos, that would value the vaping product supplier at approximately $30bn.
Salubris Pharmaceuticals invested $10m to lead a NantKwest-backed round as part of a Chinese licensing agreement for Viracta's herpes therapies.
The parking app developer has lined up SoftBank as lead investor in a round in which it is looking to raise $800m to $1bn, with Mubadala Investment also set to take part.
Kidney disease drug developer Variant has raised $10m from new strategic partner Incon in connection with a distribution agreement.
The ride hailing app is in advanced talks to invest $100m in the round which includes contribution from SoftBank Vision Fund and values the hotel operator at $5bn.
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.